ASTRAZENECA PLC

CIK 0000901832 · SEC filing index. Filing dates describe disclosures, not live market data.

Listed symbols

AZN on NYSE

Ownership signals CIK-linked ownership evidence from parsed SEC filings. 1 signal

Parsed SEC ownership signals

Largest active 13D stakes

Active large-stake positions disclosed in parsed Schedule 13D filings.

CLLS Innate Pharma SA

Largest active 13G stakes

Passive or institutional large-stake positions disclosed in parsed Schedule 13G filings.

MNPR CDT

How to read these SEC ownership signals

• Read each filing family separately: Form 13F, Schedules 13D/G, and Forms 3/4/5 answer different SEC disclosure questions and should not be blended into one ownership total.
• Use 13F values for visible U.S.-listed equity portfolios, 13D/G rows for large beneficial-owner stakes, and Forms 3/4/5 rows for reporting-owner positions and transactions.
• Open the linked research path when you need the filing, CIK, issuer, CUSIP, date, or source trail behind a value.

At a glance Names, identifiers, and filing context for this profile. 2 identity fields

SEC industry group

Pharmaceutical Preparations (Office of Life Sciences)

Business address

1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, CB2 0AA

EDGAR profile Static EDGAR fields kept behind disclosure so the main profile stays readable. 3 profile fields available

Incorporated in

United Kingdom

Fiscal year end

31 December

Former names on EDGAR

ZENECA GROUP PLC (to 05 Feb 1999)